The osseous regeneration of large bone defects is still a major clinical challenge in maxillofacial and orthopedic surgery. Previous studies demonstrated that biphasic electrical stimulation (ES) stimulates bone formation; however, polyimide electrode should be removed after regeneration. This study presents an implantable electrical stimulation bioreactor with electrodes based on liquid crystal polymer (LCP), which can be permanently implanted due to excellent biocompatibility to bone tissue. The bioreactor was implanted into a critical-sized bone defect and subjected to ES for one week, where bone regeneration was evaluated four weeks after surgery using micro-CT. The effect of ES via the bioreactor was compared with a sham control group and a positive control group that received recombinant human bone morphogenetic protein (rhBMP)-2 (20 μg). New bone volume per tissue volume (BV/TV) in the ES and rhBMP-2 groups increased to 132% (p < 0.05) and 174% (p < 0.01), respectively, compared to that in the sham control group. In the histological evaluation, there was no inflammation within the bone defects and adjacent to LCP in all the groups. This study showed that the ES bioreactor with LCP electrodes could enhance bone regeneration at large bone defects, where LCP can act as a mechanically resistant outer box without inflammation.
Introduction
Regeneration of large bone defects has been a challenging issue in maxillofacial and orthopedic surgery. Although there are efficient and well-established treatments, such as distraction osteogenesis and autologous bone grafting, all methods have limitations that are being tackled by many researches [12] . Distraction osteogenesis can achieve bone regeneration by moving existing bone at the speed of osteogenesis in the stretched callus, where the time needed for the treatment is proportional to the defect size [19] . Autologous bone grafting, being current gold standard, can achieve bone union regardless of the defect size with advanced surgical techniques [3] ; however, donor site morbidity is inevitable after the harvesting of the graft. Other bone regeneration treatments with osteoconductive cell-free substances, such as allogenic, xenogenic, or alloplastic bone grafts, showed low osteogenesis efficacy with long regeneration times [26, 53] . Bone regeneration with a growth factor, such as recombinant human bone morphogenetic protein (rhBMP)-2, showed enhanced Chaebin Kim and Hoon Joo Yang contributed equally to this work. bone quantity with reduced regeneration time in the clinical application [21, 46, 71] .
Bone morphogenetic protein (BMP) is a well-known osteoinductive signaling chemokine that causes bone formation by recruiting stem cells and differentiating them into bone-forming cells [36] . Among the BMP family, rhBMP-2 is widely used for bone tissue engineering because of its effectiveness in bone formation and its commercial accessibility. Despite its efficacy, rhBMP-2 is rapidly diffused when injected in vivo; hence, often, high dose is required to obtain sufficient osteoinductive effect [67] . However, high dosage of rhBMP is associated with soft tissue hematoma swelling, radiculopathy, cyst-like bone formation, bone resorption, and inflammation [11, 43, 56, 65, 77] . Moreover, cell proliferation is not stimulated by rhBMP-2, while numerous cells are required for bone regeneration at large bone defects.
Direct implantation of precultured stem cells is a straightforward and effective method [35, 75] . However, the application of stem cells for bone regeneration requires multiple complicated procedures, such as tissue harvesting, separation of the stem cells, and cultivation of cells for proliferation and differentiation, which are accompanied by long culture times, high costs, and the risk of infection [9] . Moreover, the efficacy of stem cell transplantation is low due to the low survival rate after transplantation, especially in large bone defect due to insufficient angiogenesis [2] .
To overcome the aforementioned limitations in bone regeneration, tissue prefabrication or prelamination techniques have been introduced for the regeneration of large bone defects. First, an avascular scaffold is vascularized after its implantation into well-vascularized tissue for a period; then, the vascularized scaffold with vessel pedicle is transferred to the tissue defects [24] . Based on this regenerative concept, tissue engineering components (scaffold, cells, and growth factors) are implanted into an adequate anatomical site that can provide regenerative microenvironments with well-vascularized tissue, and the components are cultivated within living body tissue using intracorporeal self-regenerative function that acts as an in vivo bioreactor [24] . However, most large bone defect sites have reduced vascularity owing to the previous operations, infection, or trauma, and, thus, they cannot provide optimal regenerative microenvironments. Therefore, new bone tissue should be first engineered at a wellvascularized ectopic site and, then, transferred to the bone defect site with vascular pedicles in the second surgery. Instead of such uncomfortable second surgery for surgeons and patients, it is preferable that regenerative microenvironments at bone defect sites can be improved by an appropriate physical stimulation, such as electrical stimulation (ES) [41, 42, 51] ; thus, tissue engineering components without vascular pedicles can be directly transferred into the osseous defect site.
ES modulates osteogenic activities of the stem cells, which can sense and react to the electric field [10] . ES has a positive effect on proliferation of bone cells, bone mineralization, and expression of bone-related growth factors and chemokine genes [5] . Recently, biphasic electric current stimulation was proposed to be used in bone regeneration for the safety of ES by achieving charge balance [37] . The biphasic electrical current stimulation on three dimensionally cultured mesenchymal stem cell accelerates the expression of chemokine receptors related to migration of the bone cells to the bone defect [42] . In our previous report, the feasibility of intracorporeally installed electrical stimulators as a form of in vivo bioreactor for enhanced bone regeneration at large mandibular bone defects was demonstrated [42] . However, the flexible electrodes did not have enough mechanical strength to maintain defect space against soft tissue tension after wound closure and external force during bone regeneration. Moreover, electrodes should be eliminated in the second surgery, because the electrodes used in the previous study were not integrated to the bone and may hinder bone union owing their area covering the cross-section of the defect.
Recently, liquid crystal polymer (LCP) has been introduced as a substrate for electrodes in implantable medical devices for ES [28, 66] . LCP is compatible with microfabrication process, such as micro-electro-mechanical system (MEMS) technology; i.e., electric conductors can be patterned on an LCP film [31] . Also, LCP is a thermoplastic which can be thermally bonded and deformed; hence, LCP based electrode can have a multilayer structure as well as a three dimensional shape [28, 30] . LCP has very low moisture absorption rate, which makes the LCP-based electrode electrically and mechanically stable in a body fluid [49] . In addition, LCP is a biocompatible material that is confirmed by in vitro cytotoxicity test following the International Organization for Standardization (ISO) 10993-5 [4] and chronic in vivo implantation over 2 years in rabbit [28] . Regarding bone implants, LCP is a biomaterial that has a mechanical strength similar to that of bone and an excellent affinity to bone [27, 33] . LCP can be effectively applied as an outer box or a scaffold for bone regeneration with ES in the orthopedic and maxillofacial field, because the material can be integrated into the regenerated bone; therefore, its removal is not necessary. On this basis, we developed an implantable bioreactor with LCP electrodes, where LCP can act as a mechanically resistant outer box in bone defect. The aim of the present study was to evaluate the regeneration of new bone with or without ES, compared to that by rhBMP-2 without ES, at a large bone defect of the mandibular body in rabbits.
Methods

Fabrication of bioreactor
The bioreactor consisted of an LCP outer box containing gold electrodes, an electrical stimulator with a battery, and absorbable collagen sponges (ACSs) that were located within the LCP outer box. The LCP outer box was designed to fit the rabbit mandibular bone defect, and its mechanical strength was sufficient to maintain the defect space necessary for bone regeneration. It was composed of the following three walls: the buccal, lingual, and bottom walls; therefore, the residual three walls (upper, mesial, and distal walls) in the hexahedral bone defect were covered with autogenous bone walls after mandibular bone resection, from which cell migration, angiogenesis, and new bone ingrowth into the defect space could occur. Two patterned gold plates were embedded inside the LCP outer box to make the electric current flow across the bone defect as shown in Fig. 1a-d . ACSs were placed inside the LCP for osteoconductive bone regeneration as in Fig. 1e . The electrical stimulator, with a battery that was implanted in the submandibular area, was connected with the gold electrodes of the LCP outer box through the lead that was fabricated together with the electrodes as depicted in Fig. 1f .
LCP outer box with gold electrodes
The LCP outer box was fabricated using LCP films (Vecstar, Kuraray, Tokyo, Japan) as in Fig. 2 . The LCP outer box was made as follows: First, an LCP film was attached on a silicon wafer using a spin-coated silicone elastomer. Gold and titanium seed layer were deposited on the film using e-gun evaporator (ZZS550-2/D, Maestech, Pyeongtaek, Korea). The LCP film was dry etched with oxygen gas using plasma etcher (PlasmaPro System100 Cobra, Oxford Instruments, Abingdon, United Kingdom) for better metal adhesion. Photoresist (AZ4620, MicroChemicals, Ulm, Germany) was spin coated on the film for photolithography. The photoresist was patterned by photolithography using mask aligner (MA-6, SUSS MicroTec, Garching bei München, Germany). On the exposed gold layer, an additional gold layer with thickness of 5 μm was electroplated, and, then, the photoresist and metal seed layers were wet-etched using photoresist remover, a mixture of nitric acid and hydrochloric acid, and hydrofluoric acid solution. Then, the LCP film was detached from the silicon wafer and laminated with bare LCP films for insulation and thickness control using heat press (model 4330, Carver, Wabash, USA). The outline of the film was cut with a laser, and the electrode site was ablated with a laser (355 nm UV, Samurai system, DPSS Lasers, Santa Clara, USA). This LCP film was then thermoformed using prefabricated molds into a shape that could adapt to the rabbit mandibular bone defect. The following two molds were fabricated: the outer mold was designed to possess the shape of the rabbit mandibular body with the created bone defect and the inner mold was designed to deliver pressure to the LCP film. For the deformation, the LCP film was fixed in the outer mold and heated using the heat press. After the temperature reached 230°C, the inner mold was inserted in the outer mold to deform the LCP conformably to the surface of the outer mold. The temperature was maintained for 15 min before the LCP was cooled down. Then, the LCP was detached from the mold and treated with oxygen plasma followed by cleaning in ethyl alcohol in 60°C and isopropyl alcohol in 70°C.
After these procedures, the LCP electrodes possessed an identical U shape to the mandibular body surface shape prior to surgical resection, with dimension of 15 mm in length (anterior-posterior), 7 mm in height, and 6 mm in depth. The thickness of the LCP was adjusted to be 325 μm to provide sufficient mechanical strength for the maintenance of the defect space. On the inner buccal and lingual surface, gold electrodes were patterned to perform the ES at the bone defect space. The dimension of gold electrodes on both surfaces was 10 × 5 mm 2 . To facilitate ingrowth of new vessels and cells for transporting nutrition across the bioreactor, multiple micro-holes (500 μm in diameter) were made, with 2-mm distance between micro-holes. Four macro-holes were made at the upper corners of buccal and lingual LCP sides for the stabilization of the LCP with screws to the mandibular bone. An extension plate with 2 mm width and 50 mm length was made for connection with the electrodes from the electric stimulator.
Electric stimulator
The electrical stimulator consists of a printed circuit board (PCB), a battery, and packaging as shown in Fig. 3 . The electrode and battery are electrically connected to the PCB through stranded wires using electrically conductive silver epoxy. The PCB has the circuit elements of a switch, a power regulator, and an application-specific integrated circuit (ASIC), where ASIC was previously designed in semiconductor fabrication process (CMOS 0.18 μm foundry, Samsung Electronics, Suwon, Korea) [41] . ASIC chip was wire-bonded onto the PCB, and the other circuit components were manually soldered. During the assembly, the electrical stimulation parameters were set to current magnitude of 20 μA, duration of 100 μs, and frequency of 100 Hz. The electric stimulator was connected to the LCP electrode and a coin battery (CR1620, Panasonic, Kadoma, Japan) using wire and silver paste. The coin battery and the electric stimulator were packaged using silicone elastomer (MED-6215, Nusil, Carpinteria, CA, USA) for implantation into the submandibular area. After testing the operation of the electrical stimulator, it was soaked in a 70% ethanol solution for a day for sterilization.
Scaffold
Sterilized absorbable collagen sponge (ACS) sheets of 1 mm thickness were purchased (Dalim Tissen Co. Ltd., Seoul, Korea) and were cut into rectangle with dimensions of 15 mm width and 7 mm length. The ACS sheets were composed of atelocollagen, which is obtained by eliminating the telopeptide from collagen molecule to reduce immune reaction.
Surgical procedure
Fifteen bone defects of ten male rabbits (New Zealandia rabbits, weight 3-3.5 kg) were used in this study. In the experiment to test the effect of ES, the bone defects were divided into three groups. The control group (n = 5) received neither ES nor rhBMP-2 after surgery for the implantation of the bioreactor. In the ES group (n = 5), biphasic ES (10 ms time cycle, 100 μs duration, 20 μA magnitude) was applied to the bioreactor for one week immediate after the implantation of the bioreactor. In the rhBMP-2 group (n = 5), rhBMP-2 (20 μg/defect) was injected into the defect space one week after the implantation of the bioreactor without ES.
All animal experiments were performed in accordance with the "Recommendations for handling Regulation for Fabricated LCP outer box whose shape and size are tailored to the target bone defect. the structure of the outer box is halfcylindrical shell whose crosssection is U shape. Size of the outer box is 15 mm in length, 7 mm in height, and 6 mm in width. Thickness of the shell is 0.35 mm, and interconnection line of 5 cm length is extended for connection to the electric stimulator Laboratory Animals for Biomedical Research" compiled by the Committee on the Safety and Ethical Handling Regulation for Laboratory Experiments in the School of Dentistry at Seoul National University. After general anesthesia using ketamine (20 mg/kg, Yuhan, Seoul, Korea) and xylazine (Rompun, 10 mg/kg, Bayer, Leverkusen, Germany) and skin disinfection with 10% povidone-iodine (Betadine, Purdue Pharma, Stamford, CN, USA), the mandibular body was exposed by incision into the skin and muscle dissection. Defect area to be resected (rectangular shape; 15 mm long, 7 mm high from the mandibular inferior border) was marked on the mandibular bone under the tooth bilaterally and osteotomized by rotary drilling machine, where alveolar bone with teeth was preserved (height of bone: 7 mm) with continuity with the residual mandibular bone. Because mandibular stabilization with mini-plates after the resection of mandibular body including the alveolar bone with teeth was unstable [41] , postoperative dislocation of the anterior segment with loosening of mini-plates and screws occurred in our previous experiments due to the strong jaw movement. The bioreactors were positioned into the defect side, stabilized with screws on the neighboring mandibular bone as in Fig. 4 , and the electric stimulator with battery coin was implanted at the submandibular area, and, then, the incision sites were sutured layer by layer. The bioreactor and the electric stimulator remained at the bone defect for the duration of this experiment. Four weeks after the surgery, the animals were sacrificed, and the defect sites, including the neighboring bone, were resected for microcomputed tomography (micro-CT) and histological evaluation. The electrical stimulator was cut out and removed during the resection. The resected bone tissues were fixed by dipping them in 10% formalin solution. 
Micro-CT
Micro-CT scan was taken for quantitative evaluation of new bone formation using SkyScan 1172 microfocus X-ray system (Bruker microCT, Kontich, Belgium). The SkyScan 1172 microfocus X-ray system is equipped with a microfocus Xray tube with a focal spot of 2 mm, producing a cone beam that is detected by a 12-bit cooled X-ray camera CCD fiber optically coupled to a 0.5 mm scintillator. The resulting images were 2000 × 1048 pixel square images with an aluminum filter used to produce optimized images with voxel size of 17 μm. A second-order polynomial correction algorithm was used to reduce the beam-hardening effect for all the samples. Reconstructions and analyses were performed using NRecon 1.6.10.4 reconstruction (Bruker microCT, Kontich, Belgium) and CTAn 1.15.4.0 software (Bruker microCT, Kontich, Belgium), respectively. The reconstructed image was rotated three dimensionally for analysis using DataViewer (Bruker microCT, Kontich, Belgium). The 3D image was obtained using CTvox 3.0 (Bruker microCT, Kontich, Belgium).
In the reconstructed image, the bone was isolated from the soft tissue and noises by the adjustment of the brightness threshold of the pixel. The lower threshold of 115 was used to distinguish bone from the noises and soft tissue. The predefined defect area was selected as the region of interest (ROI) in two-dimensional images. The pixel zone representing ossification in the defined ROI was then reconstructed in 3D by setting the lower and upper ranges of the threshold using grayscale units. On each reconstructed BMP file, the bone volume per tissue volume (BV/TV), trabecular thickness (Tb.Th), trabecular separation (Tb.Sp), and trabecular number (Tb.N) were obtained using the CTAn 1.15.4.0 software according to the manufacturer's instructions. To measure the bone mineral density (BMD), attenuation data for ROI or VOI were converted to Hounsfield units and expressed as a value of the BMD using a phantom (Bruker microCT, Kontich, Belgium). This phantom contained rods of calcium hydroxyapatite (CaHA) having a standard density corresponding to rabbit bone, which ranges from 1.26 to 1.65 g/cm 3 . BMD values were expressed in grams per cubic centimeter of CaHA in distilled water. A zero value for BMD corresponded to the density of distilled water alone (no additional CaHA), and a value greater than zero corresponded to non-aerated biologic tissue.
Newly formed bone was evaluated by two different methods. First, it was done in the whole bone defect space. In the second method, it was measured in the following five subparts; superior-buccal part, inferior-buccal part, superiorlingual part, inferior-lingual part, and central part, as shown in Fig. 5 . The upper boundaries of superior-buccal and superiorlingual parts were located at the upper surface of the bone defect, and the lower, buccal, and lingual boundaries of each subpart were positioned at the lower, buccal, and lingual surfaces of the LCP outer box. The central subpart was in the middle part in terms of the buccolingual width and the superior-inferior height of the whole bone defect. The region of interest was 15 mm in length (anterior-posterior), 2 mm in width, and 2 mm in height.
Histological evaluation
After the CT image was taken, the resected bone tissues were further decalcified in an ethylenediaminetetraacetic acid solution (7%, pH = 7.0) for 1-2 weeks. The LCP outer box and gold electrode were carefully removed from the bone tissue. Then, the tissue samples were immersed in 70% ethanol and embedded in paraffin. For histochemical staining, decalcified paraffin sections were cleaned for 10 min with xylene and stained with Masson's trichrome (MT). The decalcified specimens were sagitally cut at the middle plane of mandibular buccolingual width in the anteroposterior direction of the bone defect. Digital images of the stained sections were collected using a transmission and polarized light Axioscope microscope (Olympus BX51, Olympus Corporation, Tokyo, Japan).
Statistical analysis
The differences among the bone parameters in the three groups were first tested using Kruskal-Wallis H: test and then analyzed using Mann-Whitney U test. All statistical analyses were carried out using SPSS software (SPSS 25, IBM, NY, USA). A p-value < 0.05 was considered to indicate statistically significant differences. 3 Results
Macroscopic evaluation
Surgery sites, including incision and bone defect area, were healed without infection or wound dehiscence. LCP electrodes were maintained in the stabilized position without displacement. No inflammatory signs were seen between the skin and the bioreactor. All animals could be involved in the evaluation for micro-CT and histology.
Micro-CT analysis
Bone regeneration in whole bone defect
Osseous regeneration was dominant close to the existing bone and on the LCP surface. In the superior part of the bone defect, new bone grew from the osteotomized upper surface of the trabecular bone in the alveolar process. In the anterior and posterior parts of the bone defect, bone regeneration was from the resected anterior and posterior surfaces. In the rhBMP-2 group, new bone was formed on both the inside and outside of the lingual and buccal LCP surface, where more bone was formed on the outside of the surface than on the inside of the surface. In the ES group, new bone was formed more on the inside surface than on the outside surface. In the control group, only a tiny amount of new bone was formed both on the inside and outside surfaces. On the inferior surface of the LCP, all groups showed only small amounts of bone formation, while the ES group showed some bone formation on the inside surface compared to the amounts in the other two groups.
The amount of newly formed bone volume per defect tissue volume (BV/TV) was 132% greater in the ES group (11.9 ± 1.3%, p < 0.05) and 174% greater in the rhBMP-2 group (15.8 ± 1.5%, p < 0.01), compared to the control group (9.0 ± 2.1%) as shown in Fig. 6 , Table 1 1.568 ± 0.010 g/cm 3 ). The Tb.Th and BMD values of the native bone on the buccal side of the alveolar process from the neighboring bone were 0.29 mm and 1.75 g/cm 3 , respectively. Tb.N was significantly greater only in the rhBMP-2 group (1.34 ± 0.25 mm −1 , p < 0.01) compared to that in the control group (0.80 ± 0.15 mm −1 ). In the comparison between ES and rhBMP-2 groups, BV/TV and Tb.N were significantly higher in the rhBMP-2 group than in the ES group (BV/TV: p < 0.01; Tb.N: p < 0.05). In summary, the rhBMP-2 group was superior in BV/TS and Tb.N compared to the ES group, while the ES group was superior to the rhBMP-2 group in terms of BMD and Tb.Th as in Fig. 6 .
Bone regeneration at five subparts
BV/TV was significantly higher at the superior subparts (34.1 ± 15.8%) than at the inferior and central subparts (inferior: 2.4 ± 2.2%, p < 0.01; central: 4.7 ± 3.5%, p < 0.01) and significantly higher at inferior subparts than at central subparts (p < 0.01). BV/TV at both buccal and lingual subparts (20.9%, p < 0.01; lingual: 17.8%, p < 0.01) was significantly greater than that at the central subparts (2.4 ± 2.2%), while there was no significant difference in new bone formation between the lingual and buccal subparts.
The values of BV/TV and BV within the five subparts are presented in Table 1 . In the superior subparts, the ES and rhBMP-2 groups showed significantly greater BV/TV and BV values than the control group. The superior-buccal subpart showed a 205% increase of BV/TV in the ES group (32.1 ± 10.5%, p < 0.05) compared to that in the control group (16.2 ± 4.2%), while BV/TV in the rhBMP-2 group (48.7 ± 10.8%, p < 0.01) was 301% greater than that in the control group. In terms of BV, the superior-buccal subpart showed a 203% increase in the ES group (16.5 ± 5.7 mm 3 , p < 0.05) compared to that in the control group (8.1 ± 1.9mm 3 ), while the BV in the rhBMP-2 group (26.6 ± 7.8mm 3 , p < 0.01) was 328% greater than that in the control group. The superior-lingual subpart showed a 239% increase of BV/TV in the ES group (39.5%, p < 0.01) compared to the control group (16.5%), while BV/ TV in the rhBMP-2 group (48.7%, p < 0.01) was 310% greater than that in the control group as in Fig. 8a, and 8f . In terms of BV, the superior-lingual subpart showed 246% increased BV in the ES group (19.9 ± 3.1 mm 3 , p < 0.01) compared to that in the control group (8.1 ± 2.7 mm 3 ), while BV in the rhBMP-2 group (26.9 ± 7.8 mm 3 , p < 0.01) was 332% greater than that in the control group.
In other parameters of the superior-buccal subpart, Tb.Th and BMD were significantly higher in the ES (Tb.Th: 0.21 ± 0.08mm, p < 0.05; BMD: 1.64 ± 0.04 g/cm 3 , p < 0.05) and rhBMP-2 (Tb.Th: 0.37 ± 0.13 mm, p < 0.01; BMD: 1.70 ± 0.05 g/cm 3 , p < 0.01) groups than those in the control group (Tb.Th: 0.12 ± 0.02 mm; BMD: 1.58 ± 0.01 g/cm 3 ) as shown in Fig. 8b-e .
In the superior-lingual subpart, Tb.Th was significantly higher in the ES and rhBMP-2 groups (0.24 ± 0.02mm, p < 0.01) (0.19 ± 0.02 mm, p < 0.01) compared to that in the control group (0.12 ± 0.01 mm). Tb.N was significantly higher in the ES and rhBMP-2 groups (ES: 2.14 ± 0.45 mm −1 , p < 0.05; rhBMP-2: 2.05 ± 0.22 mm −1 , p < 0.05) compared to that in the control group (1.39 ± 0.34 mm −1 ). Tb.Sp was significantly lower in the ES and rhBMP-2 groups (ES: 0.23 ± 0.07 mm, p < 0.05; rhBMP-2: 0.24 ± 0.05 mm, p < Fig. 8g-j. In the inferior and central subparts, there was no significant difference in BV/TV among the three groups. The other values of micro-CT parameters and statistical significances are presented in Table 2 .
Histological evaluation
The histological images stained in Masson's trichrome showed that the new bone regenerated in the bone defect area without inflammation in all groups, and none of the cases showed inflammatory cells at the interface between LCP and newly formed bone area as in Fig. 9 and Fig. 10 . Interestingly, thin new bone formation was observed along LCP at the inferior bone defect boundary as depicted in Fig. 9o, Fig. 9u and Fig. 10a -c, and especially thin osteoid layer was seen along the LCP surface as in Fig. 9b , which indicated good biocompatibility of LCP for new bone formation. Excessive new bone formation could be seen at the inferior area of LCP in the rhBMP-2 group, probably due to the downward permeation of injected rhBMP-2 through the micro-holes of LCP as shown in Fig. 10c . In the control group, most new bone was thin and located near the neighboring bone surface defect with limited new bone ingrowth toward the central part as shown in Fig. 9a, and Fig. 9d-h. In the ES and rhBMP-2 groups, new bone was thicker; therefore, more ingrowth into the central part compared to that in the control group was observed as shown in Fig. 9b, Fig. 9j-o, Fig. 9c, and Fig. 9p -u.
Discussion
This study addressed the effect of an in vivo bone bioreactor with ES on bone regeneration at a large mandibular defect. We designed the bioreactor which was connected to custom-made electrodes based on LCP without stem cells or growth factor factor as shown in Fig. 11 . LCP prevents the penetration of soft tissue into the defect space and is biocompatible with the bone. It is also mechanically stable and can therefore hold the shape of the bioreactor and promote intramembranous ossification. Our bioreactor system is based on the previous reports that biphasic ES increased cell proliferation of human stem cells, such as human mesenchymal stromal cell (hMSC), and several growth factors, such as vascular endothelial growth factor (VEGF), BMP-2, and interleukin-8 (IL-8) [41, 42] . These properties provide a great potential to create favorable microenvironments for bone regeneration. VEGF is a critical factor for angiogenesis, and IL-8 is a chemokine to recruit stem cells. The effect of the biphasic electric current onlong and thin cells, such as MSC, is known to be proportional to the space derivative of the electric field [48, 62] , which is large near the electrode surface. The increased VEGF production of cells near the electrode leads to a gradient of VEGF toward the electrode, encouraging angiogenesis following gradient direction [17] . An ACS sheet has a porous structure that supports the proliferation and differentiation of bone cells with superb cell affinity [59] . The molecular structure of ACS has electric polarity that holds rhBMP-2 on the surface of ACS with electrostatic force [16] . This in vivo bioreactor system with ES benefits from one-staged direct application compared to a two-staged procedure where first the bioreactor is transplanted to the well-vascularized heterotopic sites prefabricated, and, then, the regenerated tissue is transplanted to the orthotopic site [22, 73] . The timing and duration of ES and BMP-2 treatment is an important aspect of experimental design for optimal results. The effect of the ES in bone cells is different in different stages of cell maturation [13] . Further, the effect of the rhBMP-2 varies in different stages of bone cells [40] . The ES was conducted for one week after surgery, and BMP-2 was applied one week after surgery in this present study, based on reports that bone cell culture showed active proliferation but rare mineral deposition in the first week, while deposition was observed with declined proliferation after two weeks [14, 45] . In addition, after fracture, cell proliferation lasted for 7 days, and, then, the cell differentiation and bone fusion occurred [70] . Furthermore, in the animal experiment with ES and BMP-2 [41] , new bone formation was 163% higher (p < 0.01) in the group for which the BMP-2 application was delayed until one week after ES compared to that in the group with the simultaneous application of ES and BMP-2. It seems that delayed BMP-2 application after the cell proliferation period is more efficient than immediate application after surgery.
Liquid crystal polymer (LCP) is a biocompatible material [4] , and its mechanical strength is similar to that of the bone [29, 33] . For example, the elastic modulus and tensile strength [31] , and those values of human mandibular bone are 10-19 GPa and 125-135 MPa, respectively [63] . Because of the similarity in the mechanical strength and a good fixation-to-bone property [34] , this material is considered adequate for orthopedic applications. Furthermore, it is chemically inert, allows hermetic sealing, and is compatible with MEMS microfabrication process with multilayer integration; hence, LCP-based implantable electronic device can be fabricated [20, 64, 76] . Studies regarding LCP-based packaging of a neural prosthetic device suggest that LCP-based electronic device is reliable for decades after the implantation [39, 57, 60] . Because of its thermo-forming property, it also allows the shape of the device to be formed to fit the target volume. To the best of our knowledge, this is the first report of an LCP-based electrode being used for bone regeneration. In this study, LCP-based electrode was used for both ES and mechanical support of scaffolds. The electrode had good mechanical characteristic for bone regeneration, and the volume of newly formed bone was higher than with our previous ES device based on polyimide [41] . Further, histochemical staining showed no inflammation, suggesting LCP is biocompatible. Micro CT images showed that the bones formed on the outer and inner surfaces of the LCP. Histochemical staining demonstrated the new bone formation near the surfaces of the LCP. Our study suggested that electric stimulation with the implanted bioreactor based on LCP was effective in bone regeneration.
ES has been widely used as a method to enhance bone regeneration [8, 47, 52] and nerve regeneration [39, 50] . ES increases proliferation, calcium deposition, and alkaline phosphate activity of bone-related cells [15, 38] . ES is known to open voltage-gated calcium channels to increase intra-cellular calcium ions [7] , which activates the cytoskeletal calmodulin [5] . Calcium/calmodulin complex binds to and activates enzymes, such as calcium/calmodulin-dependent protein kinase (CaMK) [6] , calcineurin (Cn) [74] , and nitric oxide synthase (NOS) [69] . CAMK enhances cell proliferation by activating cAMP response element-binding protein (CREB) [61, 72] and cyclin-dependent kinase (CDK) with cyclin [32] . Cn activates the nuclear factor of activated T-cells (NFAT) and translocates the transcription factor to the nucleus [23] . Although NFAT is associated with osteoclast activation and early bone resorption [44] , NFAT enhances the proliferation of osteoblast during fracture repair [1] . NOS promotes cell proliferation by increasing nitric oxide levels [58] . ES also made the cellular environment more suitable for osteogenesis [41] . The effect of ES included increased gene expression of type I collagen and prostaglandin [38] , growth factors (BMP-2, IGF-1, VEGF), and chemokines with receptors [42] . ES activates mitogenactivated protein kinase (MAPK), leading to increased induction of VEGF and BMP-2 of bone cells [37, 38] . Additionally, ES increases transforming growth factor (TGF)-β1 through the calcium calmodulin pathway [79] . In the present study, micro-CT evaluation showed that the bone volume in the ES group was 132% that of the control group. This result matched that of our previous experiment of ES in a dental implant, where the bone area in the ES group was 130 to 135% of bone area in the control group [37] . Even though ES could stimulate new bone regeneration, its effect on the amount of new bone formation was less than rhBMP-2 applied one week after surgery. It seems that enhanced cell differentiation by BMP-2 of small cell numbers is more efficient in bone regeneration than enhanced cell proliferation and differentiation by ES. However, Tb.Th and BMD were significantly higher only in the ES group compared to the control group, while there was no significant difference between the rhBMP-2 and control groups. These results suggest that new bone formation would be further enhanced in cases with initial ES for one week followed by rhBMP-2 application.
The effect of stimuli like ES or rhBMP-2 on bone regeneration can be different depending on the abundance of vascularity and stem cells. Corresponding to this expectation, new bone formation was predominant at the defect space adjacent to the existing host mandibular bone in the present study. Bone regeneration by ES was highest at the superior subpart of the bone defect than the other subparts. This subpart was covered with more adjacent host bone surface, including upper defect surface, providing more chance for stimulation of pre-existing blood vessels and stem cells by proximal electrode. Based on the simulation that the spatial derivative of the electric field is at its maximum near the electrode and gradually decreased as moving far from the electrode, and the effect of ES is proportional to the spatial derivative of the electric field, more new bone could be observed near the LCP. Blood clots and body fluid, which filled the bone defect space after surgery, may be electrically a conductive medium, but bone regeneration at the bone defect space far from the existing host bone was poor, even with ES or rhBMP-2, because they could only be effective at the bone defect with infiltrated stem cells and ingrowing blood vessels. On the other hand, the effect of ES or rhBMP-2 on bone regeneration can be influenced by the delivery efficacy of the stimuli. According to the results of the present study and from previous animal experiments [41] , initial ES followed by a delayed BMP-2 application would be more efficient than ES or a delayed BMP-2 application alone.
Vascularization is important for osteogenesis in large bone defects [18, 55] . Biphasic electric pulses are effective for the increased secretion of VEGF from osteoblasts and stem cells [38] , which is essential in angiogenesis [54] and which stimulates new bone formation by osteoblasts [78] . A slow and steady release of VEGF promotes bone formation [68] , which can be effectively achieved through electric stimulation. In large bone defects, cell transplantation can promote bone regeneration. However, cultured cells were not transplanted in this present study, because transplanted Fig. 11 The mechanism of the effect of the proposed bioreactor. (a) Electric stimulation enhances proliferation and VEGF production, ACS supports cell attachment and allows rhBMP-2 adsorption, and the LCP outer box prevents soft tissue penetration, where the mechanical stability promotes intramembranous ossification. (b) ES opens voltage-controlled calcium ion channels, which activates various calcium/calmodulin pathways, ultimately enhancing proliferation and VEGF production. (c) A simulation shows that the space derivative of the electric field is confined within 1 mm from the surface of the LCP outer box; hence, cells close to the surface are assumed to be targeted by ES. (d) ES of one week enhances proliferation of bone cells and angiogenesis during early inflammation phase, and rhBMP-2 injection at week 1 induces differentiation of MSC to osteoblasts cells without a blood supply via angiogenesis cannot survive for more than one week, while the defect size in the present study was greater than the defect size, for which angiogenesis can be done within one week. Instead, we expected enhanced angiogenesis and cell proliferation (stem cells and preosteoblasts) by ES, which can increase new bone formation and fill bone defects. However, the amount of bone regeneration was not enough to fill full bone defects. ES was done only for one week, because ES for more than one week can increase the number of cells [25, 37] . Nonetheless, it would prevent proliferating cells from differentiating toward osteoblasts that produce new bone. Our results suggested that one week of ES is too short to regenerate large bone defects fully. Further studies of ES stimulation lasting more than one week could determine the effective duration of ES for enough bone regeneration in large bone defects.
Conclusions
In conclusion, we verified the intracorporeally implanted ES bioreactor with LCP electrodes for bone regeneration, where LCP can act as a mechanically resistant outer box in bone defect without inflammation. The bioreactor system with ES significantly increased new bone formation compared to the control without ES at a large bone defect of the rabbit mandible. The bioreactor system with ES was superior in BMD compared to rhBMP-2, while rhBMP-2 applied one week after surgery showed more enhanced osteogenesis than the bioreactor system with ES. Further experiments with other conditions of the bioreactor may be helpful to develop more effective bone regeneration treatment.
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